342 - Ogden Clinical, Grand View/CCT Research — Roy, Utah

342 - Ogden Clinical, Grand View/CCT Research is a clinical research site located in Roy, Utah, United States 84067.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

342 - Ogden Clinical, Grand View/CCT Research has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: EmitBio Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Roy

Browse all research sites in Utah · View every site in Roy

• GSK Investigational Site
• Research Site
• Wee Care Pediatrics-Roy ( Site 0053)
• Wee Care Pediatrics
• AMR Clinical
• Ogden Clinic Grandview
• Ogden Clinic - Grandview - CCT - PPDS
• Ogden Clinic
• Avacare (CCT) - Ogden Clinic - Grand View
• 117 Wee Care(Roy) 5991 South 3500 West, Suite 100
• Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 342 - Ogden Clinical, Grand View/CCT Research?

342 - Ogden Clinical, Grand View/CCT Research has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 342 - Ogden Clinical, Grand View/CCT Research conducted?

342 - Ogden Clinical, Grand View/CCT Research has 1 clinical trials on record. Their work covers COVID-19.

Is 342 - Ogden Clinical, Grand View/CCT Research accredited by Crixeo Clinical Trials?

342 - Ogden Clinical, Grand View/CCT Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 342 - Ogden Clinical, Grand View/CCT Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.